CN106619768A - Eye protection wet tissue - Google Patents

Eye protection wet tissue Download PDF

Info

Publication number
CN106619768A
CN106619768A CN201510727993.7A CN201510727993A CN106619768A CN 106619768 A CN106619768 A CN 106619768A CN 201510727993 A CN201510727993 A CN 201510727993A CN 106619768 A CN106619768 A CN 106619768A
Authority
CN
China
Prior art keywords
wet tissue
eye
parts
eye protection
protection wet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510727993.7A
Other languages
Chinese (zh)
Inventor
焦秀英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Hui Ying Datong Chemical Technology Co Ltd
Original Assignee
Qingdao Hui Ying Datong Chemical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Hui Ying Datong Chemical Technology Co Ltd filed Critical Qingdao Hui Ying Datong Chemical Technology Co Ltd
Priority to CN201510727993.7A priority Critical patent/CN106619768A/en
Publication of CN106619768A publication Critical patent/CN106619768A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to the technical field of wet tissues, more particularly to an eye protection wet tissue, which comprises a nonwoven fabric and a wet tissue liquid, wherein the wet tissue liquid comprises, by mass, 0.5-1 part of panthenol, 0.2-0.5 part of vitamin B6, 0.2-0.5 part of dipotassium glycyrrhizinate, 0.01-0.05 part of a chamomilia extraction liquid, 2-4 parts of hyaluronic acid, 10-15 parts of a pearl extraction liquid, and 50-70 parts of deionized water. According to the present invention, the eye protection wet tissue contains the moisturizing component, the anti-allergic component and the eyesight improving component, wherein the eye protection wet tissue surface with no film is applied on the eye, the effective component in the eye protection wet tissue naturally enters the eye, no irritation is generated, or the eye is directly wiped with the eye protection wet tissue, and the use is convenient and health; and through the gas-impermeable film layer, the effective component in the eye protection wet tissue can be prevented from the emitting in the environment, and the complete action of the effective component on the eye can be ensured.

Description

Eye-protection wet tissue
Technical field
The present invention relates to wet tissue technical field, particularly a kind of eye-protection wet tissue.
Background technology
Life style and the change of condition of work with people, the time with eye is more and more, such as see computer for a long time, see TV, operate video games etc., it is easy to suffer from visual fatigue disease and eyes are dry and astringent.Then many people select to use eye drops.But It is that eye drops is that directly liquid is added drop-wise in eyes, and the dropwise addition initial stage can make eyes have sense of discomfort;In addition eyes easily directly connect Tactile eye-drop liquid bottle, and one bottle of eye drops can not possibly disposably be finished, this there is the contaminated and non-serviceable situation of eye drops.
The content of the invention
It is an object of the invention to overcome the drawbacks described above that prior art is present, there is provided a kind of eye-protection wet tissue, eye is spread on when using Portion, makes active ingredient distribute to intraocular using the temperature of body, eyeball is not stimulated, easy to use, health.
The present invention is realized using following technical scheme:
A kind of eye-protection wet tissue, including non-woven fabrics and wet tissue liquid, the wet tissue liquid is made up of the raw material of following mass parts:Panthenol 0.5-1 Part, vitamin B6-0.2-0.5 parts, dipotassium glycyrrhizinate 0.2-0.5 parts, chamomile extract 0.01-0.05 parts, hyaluronic acid 2-4 parts, pearl extract 10-15 parts, deionized water 50-70 part.
Further, the one side of the non-woven fabrics has air-locked film layer.
Further, the size of the non-woven fabrics is that length is 15-30cm, and width is 5-15cm.
The invention has the beneficial effects as follows:The eye-protection wet tissue of the present invention contains the composition of moisturizing, antiallergy and improving eyesight;Can be by eyeshield Wet tissue spreads on eye without the one side of film, and the active ingredient in wet tissue is naturally pleasing to the eye, will not produce stimulation, or directly wipes eye Eyeball, easy to use, health;Air-locked film layer is prevented from the lost environment of active ingredient in wet tissue, it is ensured that effectively into Divide and fully act on eyes.
Specific embodiment
With reference to embodiment, the present invention will be further described.
Embodiment 1
A kind of eye-protection wet tissue, including non-woven fabrics and wet tissue liquid, non-woven fabrics preferably one side carries air-locked film layer, and its size is preferred Length is 15cm, and width is 5cm.The wet tissue liquid is made up of the raw material of following mass parts:0.5 part of panthenol, vitamin B6-0.2 Part, 0.2 part of dipotassium glycyrrhizinate, 0.01 part of chamomile extract, 2 parts of hyaluronic acid, 10 parts of pearl extract, deionization 50 parts of water.
Embodiment 2
A kind of eye-protection wet tissue, including non-woven fabrics and wet tissue liquid, non-woven fabrics preferably one side carries air-locked film layer, and its size is preferred Length is 30cm, and width is 15cm.The wet tissue liquid is made up of the raw material of following mass parts:1 part of panthenol, vitamin B6-0.5 Part, 0.5 part of dipotassium glycyrrhizinate, 0.05 part of chamomile extract, 4 parts of hyaluronic acid, 15 parts of pearl extract, deionization 70 parts of water.
Embodiment 3
A kind of eye-protection wet tissue, including non-woven fabrics and wet tissue liquid, non-woven fabrics preferably one side carries air-locked film layer, and its size is preferred Length is 25cm, and width is 10cm.The wet tissue liquid is made up of the raw material of following mass parts:0.7 part of panthenol, vitamin B6-0.4 parts, 0.4 part of dipotassium glycyrrhizinate, 0.03 part of chamomile extract, 3 parts of hyaluronic acid, 12 parts of pearl extract, 60 parts of deionized water.

Claims (3)

1. a kind of eye-protection wet tissue, including non-woven fabrics and wet tissue liquid, it is characterised in that the wet tissue liquid by following mass parts raw material Composition:Panthenol 0.5-1 parts, vitamin B6-0.2-0.5 parts, dipotassium glycyrrhizinate 0.2-0.5 parts, chamomile extract 3-5 Part, hyaluronic acid 2-4 parts, pearl extract 10-15 parts, deionized water 50-70 part.
2. eye-protection wet tissue according to claim 1, it is characterised in that the one side of the non-woven fabrics has air-locked film layer.
3. eye-protection wet tissue according to claim 1, it is characterised in that it is 15-30cm that the size of the non-woven fabrics is length, Width is 5-10cm.
CN201510727993.7A 2015-10-30 2015-10-30 Eye protection wet tissue Pending CN106619768A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510727993.7A CN106619768A (en) 2015-10-30 2015-10-30 Eye protection wet tissue

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510727993.7A CN106619768A (en) 2015-10-30 2015-10-30 Eye protection wet tissue

Publications (1)

Publication Number Publication Date
CN106619768A true CN106619768A (en) 2017-05-10

Family

ID=58809288

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510727993.7A Pending CN106619768A (en) 2015-10-30 2015-10-30 Eye protection wet tissue

Country Status (1)

Country Link
CN (1) CN106619768A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969427A (en) * 2018-10-12 2018-12-11 青岛明药堂医疗股份有限公司 A kind of Special wet tissue for eyes and preparation method thereof
CN112277473A (en) * 2020-10-25 2021-01-29 郑州奥诚电子科技有限公司 Long-acting moisturizing method and moisturizing wet tissue for spray head of ink-jet printer

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108969427A (en) * 2018-10-12 2018-12-11 青岛明药堂医疗股份有限公司 A kind of Special wet tissue for eyes and preparation method thereof
CN108969427B (en) * 2018-10-12 2021-05-04 青岛明药堂医疗股份有限公司 Special wet tissue for eyes and preparation method thereof
CN112277473A (en) * 2020-10-25 2021-01-29 郑州奥诚电子科技有限公司 Long-acting moisturizing method and moisturizing wet tissue for spray head of ink-jet printer

Similar Documents

Publication Publication Date Title
WO2014172693A3 (en) Nasal stimulation devices and methods
MX2010003774A (en) Aqueous ophthalmic formulations.
WO2011053801A3 (en) Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye
MX2017005204A (en) Stimulation devices and methods for treating dry eye.
MX2020005217A (en) Ophthalmic composition and delivery device thereof.
WO2015095772A3 (en) Formulations and methods for targeted ocular delivery of therapeutic agents
TW200633709A (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
WO2014184576A3 (en) Delivery of a therapeutic agent to the cerebral cortex by administering a viral vector by convection enhanced diffusion into the white matter of the brain
CN103357058B (en) A kind of contact lens care solution and preparation method thereof
CN106619768A (en) Eye protection wet tissue
MX2007004030A (en) Polyamine analogs as therapeutic agents for ocular diseases.
KR101656250B1 (en) wristlets
CN105853272A (en) Skin-care cleansing water
CL2020001426A1 (en) Topical ophthalmic composition comprising dobesilic acid to treat diseases of the posterior segment of the eye.
CN103845232A (en) Wrinkle-removing caring compound bath salt
WO2014182696A3 (en) Bioresorbable scaffold for neurologic drug delivery
CN102987575A (en) Anti-mosquito silk stockings
CN104846135A (en) Leather maintenance agent
CN103027437A (en) Health care shoe-pad
KR200401923Y1 (en) Horny substance prevention and stockings
CN106963719A (en) A kind of removing acnes and controlling oil facial mask
KR102558392B1 (en) A mask patch for activity
CN104498232A (en) Cool type rose fragrance hand-washing solution
CN204292337U (en) A kind of there is moisture absorption, perspire, not easily to river bend the multifunctional protection type shoe-pad of pin
CN205062037U (en) Beauty and health care soap

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170510